Drug major Sun Pharmaceuticals will close its facility at Detroit as part of a manufacturing consolidation process in the US.
The Workforce Development Agency for State of Michigan has been notified about the decision to stop operations and close the Detroit plant, which belongs to subsidiary Caraco Pharmaceutical Laboratories, Sun Pharma said in a statement.
The generic drugmaker recently inked a $3.2-billion (Rs 19,200 crore at 1 dollar = 60 rupees) deal to buy Ranbaxy Laboratories.
"The company has provided the requisite advance written notice of the facility closure to the employee union and all affected employees," it added.
Impacted employees will get compensated with more than their regular entitlement under the severance package, the Mumbai-based firm said.
"They will also receive other support services, including out-placement assistance. The rest of the employees are continuing through mutually consented arrangements," it added.
The firm said it has undertaken measures to ensure business continuity of products made at the plant.
"The manufacturing of these products is being transferred to other units and all necessary steps have been taken to avoid market shortage," it added.
Sun Pharma expects negligible impact of this development on its FY15 consolidated revenue, it added.
Shares in Sun Pharma, on Friday, ended at Rs 630 apiece on the BSE, down 0.25 per cent from the close.
RESULT
Drug major Sun Pharmaceuticals will close its facility at Detroit as part of a manufacturing consolidation process in the US.
Sun Pharmaceuticals to close Unit Caraco's Detroit ...
Drug major *Sun Pharmaceuticals Industries will close its facility at Detroit as part of a manufacturing consolidation process in the US. The Workforce Development
Caraco Pharmaceutical to close Detroit plant, lay off 178 ...
Generic drug maker Caraco Pharmaceutical Laboratories says it plans to close its Detroit manufacturing plant this Sun Pharma is one of the
India's Sun Pharma To Close Plant In Detroit
India's Sun Pharma To Close Plant In Detroit,Read most current stock market news, Get stock, fund, etf analyst reports from an independent source you can trust
Cost-cutting? Sun Pharma to shut its manufacturing plant ...
N ew Delhi: Drug major Sun Pharmaceuticals will close its facility at Detroit as part of a manufacturing consolidation process in the US. The Workforce Development
India's Sun Pharma To Close Plant In Detroit 5-2-14 1:28 ...
India's Sun Pharma To Close Plant In Detroit Sun Pharma acquired troubled Caraco after it ran afoul with U.S. regulators in 2009 for failing to meet manufacturing
Sun Pharma to shutter Detroit plant
Drug major Sun Pharmaceuticals will close its facility at Detroit as part of manufacturing consolidation. The Workforce Development Agency for Michigan state has been
Sun Pharma says US plant closure impact negligible ...
acquisition of Ranbaxy-Sun Pharmaceutical cease manufacturing operations and close the Detroit (Caraco Pharmaceutical plants Sun has in the US
Sun Pharma-Ranbaxy deal: What brokerages say - NDTVProfit.com
Sun Pharma Vows 'Appropriate Action' as Merger Halted. Sun Pharma to Close Detroit Manufacturing Plant. Ranbaxy Recalls Nearly 30,000 Packs of Allergy
Sun Pharma shuts Caraco's Detroit plant in US - The Smart ...
to shut its manufacturing plant at Detroit, Sun Pharma shuts Caraco's Detroit plant operations and close the Detroit (Caraco Pharmaceutical
